The Latest Breaking News from PBMs

GOP spending bill proposal excludes reforms for pharmacy benefit managers (PBMs) despite bipartisan expectations.

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients

Lawmakers question whether the decision to renew Express Scripts as TRICARE's pharmacy benefit manager is a wise decision.

Biden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say one strategy makes it unaffordable to keep some brand-name medicines in stock.

Rural pharmacies can be a touchstone for their communities

Learn about the controversies surrounding US pharmacy benefit managers (PBMs) and the need for increased regulation and transparency in the healthcare system.

The "Shark Tank" investor and Cost Plus Drugs cofounder Dr. Alex Oshmyansky participated in a White House health care roundtable.

A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a familiar face.